<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Patent Term Adjustment Reductions in View of the Federal Circuit Decision in Supernus Pharm., Inc. v. Iancu</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Patent Term Adjustment Reductions in View of the Federal Circuit Decision in Supernus Pharm., Inc. v. Iancu</h1>
    <p class="timestamp">Published: 2019-10-04 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The United States Patent and Trademark Office (Office) is proposing to revise the rules of practice pertaining to patent term adjustment in view of the decision by the U.S. Court of Appeals for the Federal Circuit (Federal Circuit) in Supernus Pharm., Inc. v. Iancu (Supernus). The Federal Circuit in Supernus held that a reduction of patent term adjustment must be equal to the period of time during which the applicant failed to engage in reasonable efforts to conclude prosecution of the applicati...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Proposed Rule</p>
    <p><strong>Agency:</strong> Commerce Department, Patent and Trademark Office</p>
    <p><strong>Document Number:</strong> 2019-21271</p>
    <p><strong>Publication Date:</strong> 2019-10-04</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2019/10/04/2019-21271/patent-term-adjustment-reductions-in-view-of-the-federal-circuit-decision-in-supernus-pharm-inc-v">https://www.federalregister.gov/documents/2019/10/04/2019-21271/patent-term-adjustment-reductions-in-view-of-the-federal-circuit-decision-in-supernus-pharm-inc-v</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2019-21271</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
